Promote Your Research… Share it Worldwide
Have a story or written a research paper? Become a contributor and publish your work on AcademicJobs.com.
Submit your Research - Make it Global NewsA groundbreaking study from Singapore's leading medical researchers has shed new light on why some individuals face a dramatically higher risk of developing stomach cancer, also known as gastric cancer. Published recently in the prestigious journal Cancer Discovery, the research reveals how everyday factors like advancing age, smoking habits, shifts in the oral microbiome, and specific genetic mutations can interact in a synergistic way to multiply the danger up to sixfold.
In Singapore, gastric cancer is the seventh most common cancer in men and ninth in women, with a lifetime risk for men estimated at 1 in 50. More alarmingly, over two-thirds of cases are diagnosed at advanced stages III or IV, when treatment options dwindle and survival rates drop significantly.
Unpacking the Stomach Cancer Burden in Singapore
Stomach cancer develops slowly over years or decades, often without early symptoms, making it a silent killer. In the Lion City, the disease's incidence hovers around 15 to 20 cases per 100,000 people, influenced by a mix of lifestyle, dietary, and infectious factors. Chronic infection with Helicobacter pylori (H. pylori)—a bacterium that colonizes the stomach lining—remains the biggest culprit, classified as a Group 1 carcinogen by the World Health Organization. It triggers chronic inflammation, leading to atrophic gastritis, IM, and eventually dysplasia and adenocarcinoma, the most common type of gastric cancer.
Other established risks include diets high in salted, smoked, or pickled foods—common in some Asian cuisines—and low intake of fresh fruits and vegetables. Tobacco smoking doubles the risk, while family history or pernicious anemia adds further vulnerability. Yet, not everyone exposed to these progresses to cancer. The Duke-NUS/NUHS study dives deeper, focusing on IM, a key precursor present in up to 20% of endoscopies in high-risk populations like Singapore's. By identifying why some IM cases evolve into malignancy while others remain benign, researchers aim to revolutionize risk assessment.
Professor Yeoh Khay Guan emphasizes, “It is about finding the right people, at the right time, with the right interventions before cancer takes hold.” This precision approach could shift Singapore's gastric cancer paradigm from reactive treatment to proactive prevention.
The Impact of Ageing and Clonal Hematopoiesis
Age is the strongest standalone risk factor for stomach cancer worldwide, with most diagnoses occurring after 60. The study highlights clonal hematopoiesis (CH)—mutations in blood stem cells that expand over time—as a critical age-related driver. CH, detected in 10-20% of people over 70, weakens immune surveillance, allowing pre-cancerous cells to thrive. In IM patients with CH, researchers found elevated levels of oral bacteria in stomach tissue, fostering chronic inflammation.
Genes like DNMT3A and TET2, commonly mutated in CH, alter DNA methylation and epigenetics, promoting a pro-inflammatory environment. In Singapore's ageing population—projected to have one in four residents over 65 by 2030—this underscores the urgency for tailored screening. The interplay means older smokers with IM and CH face compounded risks, but early detection via endoscopy can intervene effectively.
Smoking's Role in Oxidative Stress and DNA Damage
Smoking accelerates gastric carcinogenesis through signature mutational processes. The study identified SBS17, a DNA damage pattern from oxidative stress, prevalent in IM progressing to cancer. Cigarette smoke introduces carcinogens that overwhelm cellular repair, especially in inflamed stomachs. Smokers with IM showed higher SBS17 loads, linking directly to worse outcomes.
In Singapore, where adult smoking prevalence is around 12%, quitting could avert thousands of cases. Public campaigns like the Health Promotion Board's National Smoking Control Programme have reduced rates, but ex-smokers retain elevated risk, emphasizing lifelong vigilance.
Genetic Mutations: ARID1A Loss and Tumor Suppression Failure
ARID1A, a SWI/SNF complex gene, is mutated in 17-27% of gastric cancers. As a tumor suppressor, its loss impairs chromatin remodeling, disabling growth controls. The study found ARID1A mutations in IM predicted progression, with patients showing poorer prognosis. Combined with other hits, it tips the balance toward malignancy.
Genetic testing for ARID1A and similar markers could flag high-risk IM, guiding intensified surveillance. Singapore's advanced genomics infrastructure, via SGCC, positions it to lead in personalized oncology.
Oral Bacteria: An Unexpected Invader
Traditionally, H. pylori dominates bacterial risks, but the study spotlights oral microbes like Streptococcus species migrating to the stomach via CH-weakened barriers. These bacteria thrive in IM, perpetuating inflammation. Higher oral bacterial loads correlated with advanced lesions, suggesting poor dental hygiene as a modifiable risk.
For Singaporeans, where oral health is good but not perfect, regular dental check-ups and H. pylori testing gain importance. Eradication therapy, standard for infected individuals, cuts risk by 30-50%.
Synergistic Interactions: Why Risks Multiply
The study's power lies in showing synergy: CH (age) + SBS17 (smoking) + ARID1A mutation + bacteria = up to 6x risk hike. Oxidative damage from smoke sensitizes cells, mutations disable repair, age impairs immunity, bacteria inflame. This 'perfect storm' explains late-stage diagnoses.
Clinically, multi-omics profiling (genomics, epigenomics, microbiome) enables risk scores, prioritizing endoscopy for high-risk groups.
Behind the Science: Study Methodology
Researchers sequenced 1,500+ IM biopsies from low/high incidence countries, identifying 47 mutated genes. Multi-country validation confirmed biomarkers' universality. SGCC's organoid models tested ARID1A's role, while microbiome analysis used 16S rRNA sequencing.
Duke-NUS, a NUS-Duke collaboration, exemplifies Singapore's higher education excellence in translational research.
Screening and Prevention Strategies in Singapore
No population screening yet, per MOH guidelines, due to endoscopy's invasiveness. High-risk groups (family history, H. pylori, IM) get gastroscopy every 1-3 years per Academy of Medicine guidelines. Study advocates genetic/oral bacteria tests to refine this.
H. pylori testing via urea breath test or stool antigen, followed by triple therapy (antibiotics + PPI), prevents 1/3 cases. Lifestyle: quit smoking, balanced diet, oral hygiene.
Emerging Therapies and Future Outlook
Pyrvinium pamoate, an antiparasitic, inhibits IM growth in lab models; trials pending. SGCC explores organoids for drug screening. With Singapore's aging demographic, integrating AI-risk models into Screen for Life could save lives.
Global collaboration via SGCC positions Singapore universities as gastric cancer hubs.
Photo by Angelyn Sanjorjo on Unsplash
Takeaways for Singaporeans: Empowering Health Choices
Know your risks: age 50+, smoker, family history? Discuss H. pylori test and endoscopy. Maintain oral health, eat fresh, quit tobacco. This Duke-NUS study empowers proactive steps, potentially halving Singapore's gastric cancer toll.
For researchers, it opens doors in precision oncology—explore careers at AcademicJobs.com research positions.
Be the first to comment on this article!
Please keep comments respectful and on-topic.